No significant differences in terms of relapse-free-survival after primary melanoma (TLM) or after metastasectomy (RFS) were recorded among the NRAS, BRAF and WT/WT subgroups respect to each other (Table 4, Figure 2A and 2B). Here, BRAF is linked to melanoma.